SHSE:603235 (China)
Â
Class A
Â¥
23.96
-0.060 (-0.25%)
Jul 30
Business Description
JiangXi Tianxin Pharmaceutical Co Ltd
ISIN : CNE100005Q89
Share Class Description:
SHSE:603235: Class ATotal Employee Number:
2,893Compare
Compare
Traded in other countries / regions
603235.China Index Membership
SSE Composite Index IPO Date
2022-07-12Description
JiangXi Tianxin Pharmaceutical Co Ltd is engaged in the research and development, production and sales of monomeric vitamin products.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.74 | |||||
Equity-to-Asset | 0.81 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | 0.67 | |||||
Interest Coverage | 145.39 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 6.92 | |||||
Beneish M-Score | -2.45 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.5 | |||||
3-Year EBITDA Growth Rate | -0.7 | |||||
3-Year EPS without NRI Growth Rate | -3 | |||||
3-Year FCF Growth Rate | -49.1 | |||||
3-Year Book Growth Rate | 6.6 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 53.36 | |||||
9-Day RSI | 54.62 | |||||
14-Day RSI | 53.72 | |||||
3-1 Month Momentum % | -13.13 | |||||
6-1 Month Momentum % | -14.69 | |||||
12-1 Month Momentum % | -19.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.08 | |||||
Quick Ratio | 4.1 | |||||
Cash Ratio | 2.85 | |||||
Days Inventory | 146.55 | |||||
Days Sales Outstanding | 42.87 | |||||
Days Payable | 67.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.29 | |||||
Dividend Payout Ratio | 0.56 | |||||
Forward Dividend Yield % | 2.29 | |||||
5-Year Yield-on-Cost % | 2.32 | |||||
Shareholder Yield % | 0.01 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 39.72 | |||||
Operating Margin % | 26.41 | |||||
Net Margin % | 21.98 | |||||
EBITDA Margin % | 26.44 | |||||
FCF Margin % | 2.58 | |||||
OCF Margin % | 24.73 | |||||
ROE % | 10.71 | |||||
ROA % | 8.68 | |||||
ROIC % | 12.94 | |||||
3-Year ROIIC % | 2.18 | |||||
ROC (Joel Greenblatt) % | 17.67 | |||||
ROCE % | 11.39 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 20.13 | |||||
PE Ratio without NRI | 19.64 | |||||
Price-to-Owner-Earnings | 257.62 | |||||
PS Ratio | 4.46 | |||||
PB Ratio | 2.07 | |||||
Price-to-Tangible-Book | 2.15 | |||||
Price-to-Free-Cash-Flow | 174.89 | |||||
Price-to-Operating-Cash-Flow | 17.89 | |||||
EV-to-EBIT | 14.82 | |||||
EV-to-EBITDA | 14.82 | |||||
EV-to-Revenue | 3.92 | |||||
EV-to-FCF | 151.68 | |||||
Price-to-GF-Value | 0.83 | |||||
Price-to-Graham-Number | 1.37 | |||||
| Price-to-Net-Current-Asset-Value | 6.55 | |||||
| Price-to-Net-Cash | 27.86 | |||||
Earnings Yield (Greenblatt) % | 6.75 | |||||
FCF Yield % | 0.58 | |||||
Forward Rate of Return (Yacktman) % | 4.42 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
JiangXi Tianxin Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 2,365.889 | ||
| EPS (TTM) (Â¥) | 1.19 | ||
| Beta | 0.8366 | ||
| 3-Year Sharpe Ratio | -0.55 | ||
| 3-Year Sortino Ratio | -0.78 | ||
| Volatility % | 11.52 | ||
| 14-Day RSI | 53.72 | ||
| 14-Day ATR (Â¥) | 0.609093 | ||
| 20-Day SMA (Â¥) | 23.666 | ||
| 12-1 Month Momentum % | -19.6 | ||
| 52-Week Range (Â¥) | 21.58 - 30.02 | ||
| Shares Outstanding (Mil) | 437.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
JiangXi Tianxin Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
JiangXi Tianxin Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.550000 Cash Dividend | 2026-07-01 | 22.25 (-2.84%) | ||
| CNY 0.680000 Cash Dividend | 2025-06-17 | 28.03 (+0.83%) |
Show
Entries
JiangXi Tianxin Pharmaceutical Co Ltd Frequently Asked Questions
What is JiangXi Tianxin Pharmaceutical Co Ltd(SHSE:603235)'s stock price today?
The current price of SHSE:603235 is ¥23.96. The 52 week high of SHSE:603235 is ¥30.02 and 52 week low is ¥21.58.
When is next earnings date of JiangXi Tianxin Pharmaceutical Co Ltd(SHSE:603235)?
The next earnings date of JiangXi Tianxin Pharmaceutical Co Ltd(SHSE:603235) is .
Does JiangXi Tianxin Pharmaceutical Co Ltd(SHSE:603235) pay dividends? If so, how much?
The Dividend Yield %  of JiangXi Tianxin Pharmaceutical Co Ltd(SHSE:603235) is 2.29% (As of Today), Highest Dividend Payout Ratio of JiangXi Tianxin Pharmaceutical Co Ltd(SHSE:603235) was 0.72. The lowest was 0.36. And the median was 0.54. The  Forward Dividend Yield % of JiangXi Tianxin Pharmaceutical Co Ltd(SHSE:603235) is 2.29%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on JiangXi Tianxin Pharmaceutical Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers